Concepedia

Yi He Ling

YH

Statistics

Publications

14

Citations

1K

H-Index

13

Active since

1993

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Applied Sciences and Arts of Southern Switzerland

Supélec

Shandong University of Political Science and Law

Icahn School of Medicine at Mount Sinai

Yi He Ling is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

1993–2011

14

Publications

14

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.

Yi He Ling, Leonard Liebes, Jian Jiang et al. · PubMed · 2003 · 262 citations

Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.

Yi He Ling, Adel K. El‐Naggar, Waldemar Priebe et al. · Molecular Pharmacology · 1996 · 210 citations

PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis.

Yi He Ling, Leonard Liebes, Bruce Ng et al. · PubMed · 2002 · 188 citations

, , +16

Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice.

Román Pérez-Soler, Bonnie L. Kemp, Qing Wu et al. · PubMed · 2000 · 84 citations

, , +17

Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.

Yiyu Zou, Yi He Ling, Nguyen T. Van et al. · PubMed · 1994 · 52 citations

, , +24

1–5 of 14